Dilushi Wijayaratne
LightNews LightNews
dilushiwijay.bsky.social
Dilushi Wijayaratne
@dilushiwijay.bsky.social
690 followers 340 following 34 posts
Consultant Nephrologist| Lecturer, Colombo. #NSMC 2021|
@GlomCon Instructor |@ISNEducation | @AJKD intern 22/23 | DPhil student |RSG|@Oxford_NDPH | MSc Clinical trials(Oxon) 2021/23
Posts Replies Media Videos
Reposted by Dilushi Wijayaratne
renfamilia.bsky.social
Glad to have discussed the case for #ECNeph. Thank you all for your support and guidance! @myadla.bsky.social @dramiliflores.bsky.social @dilushiwijay.bsky.social @theisn.org 🙌
May 30, 2025 at 5:02 PM
Reposted by Dilushi Wijayaratne
theisn.org
🌍 History made! For the first time, kidney care is on the global health agenda. #WHA78 adopted a landmark resolution recognizing kidney health in the fight against #NCDs.

👏 Thanks to Guatemala and the global kidney community for making this possible!

#KidneyHealthMatters
May 23, 2025 at 2:28 PM
Reposted by Dilushi Wijayaratne
hswapnil.medsky.social
longer discussion including MRAs and ASIs here www.nephjc.com/news/2024/10...

#WorldHypertensionDay
Finerenone Finally Finishing off Spironolactone? — NephJC
A commentary putting the recent finerenone and spironolactone trials in perspective
www.nephjc.com
May 22, 2025 at 2:03 PM
Reposted by Dilushi Wijayaratne
hswapnil.medsky.social
BP Targets:

the @kdigo.org www.nephjc.com/news/kdigo-bp

The ESPRIT trial discussion www.nephjc.com/news/esprit

The BPROAD discussion
www.nephjc.com/news/bproad

#WorldHypertensionDay

#120ForAll
The KDIGO 2021 BP Guidelines — NephJC
KDIGO; BP; blood pressure; guidelines; kidney; kidney disease; CKD; transplant; bp measurement; AOBP; ABPM; ACE inhibitors
www.nephjc.com
May 22, 2025 at 1:37 PM
Reposted by Dilushi Wijayaratne
hswapnil.medsky.social
The @thelancet.com review on global BP control
www.thelancet.com/journals/lan...

Worsening BP control in Canada www.sciencedirect.com/science/arti...

Improving BP control in US from @amjhypertension.bsky.social academic.oup.com/ajh/article/...

#Hypertension #WorldHypertensionDay
Global and national high blood pressure burden and control
High blood pressure is a leading modifiable cause of premature death and one of WHO's global targets for the prevention of non-communicable diseases. Monitoring high blood pressure globally while unde...
www.thelancet.com
May 22, 2025 at 1:17 PM
Reposted by Dilushi Wijayaratne
hswapnil.medsky.social
K issues
#NephJC www.nephjc.com/news/salt-su...
Podcast www.nephjc.com/freelyfilter...

K switch mechanism
pubmed.ncbi.nlm.nih.gov/38081406/ in @ajkd.bsky.social

pubmed.ncbi.nlm.nih.gov/37772757/ from @amjhypertension.bsky.social

journals.physiology.org/doi/full/10....

#WorldHypertensionDay
The Na-K Exchange Saves Lives — NephJC
This week, we will discuss the SSASS trial. in which a simple switch of table salt with a K-enriched salt works miracles. Is it about the sodium or the potassium?
www.nephjc.com
May 22, 2025 at 2:31 PM
Reposted by Dilushi Wijayaratne
hswapnil.medsky.social
The ARNI data in CKD here pubmed.ncbi.nlm.nih.gov/30002098/

#WorldHypertensionDay
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease - PubMed
URL: http://www.isrctn.com . Unique identifier: ISRCTN11958993.
pubmed.ncbi.nlm.nih.gov
May 22, 2025 at 2:36 PM
Reposted by Dilushi Wijayaratne
theisn.org
#23 𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for next Space #WorldHypertensionDay: "Hypertension and the Kidneys."

@edgarvlermamd.bsky.social @hswapnil.medsky.social @myadla.bsky.social @dilushiwijay.bsky.social @ferarceamare.bsky.social
🗓️ May 22
🕑 3:00 pm CEST
⏰ Set your alarm here: twitter.com/i/spaces/1jM...
May 17, 2025 at 6:55 AM
dilushiwijay.bsky.social
Thanks, milagros #NephJC
May 14, 2025 at 1:59 AM
dilushiwijay.bsky.social
Another great question about tranexaminc acid in urological bleeding.. we usually use it for post-biopsy bleeds. Does anyone have reservations about this? #NephJC
May 14, 2025 at 1:58 AM
dilushiwijay.bsky.social
Same with us, but sometimes due to lack of availability switch to 18G for native. There are always concerns about adequacy when this happens #NephJC
May 14, 2025 at 1:56 AM
Reposted by Dilushi Wijayaratne
juancarlosqvelez.bsky.social
#NephJC One of my fave all time papers in this topic is a proof-of-concept DDAVP in CKD: reduces bleeding time consistently @nejm.org pubmed.ncbi.nlm.nih.gov/6401193/
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia - PubMed
In a randomized double-blind cross-over trial we gave either 1-deamino-8-D-arginine vasopressin or placebo to 12 patients with uremia, hemorrhagic tendencies, and prolonged bleeding times. After vasop...
pubmed.ncbi.nlm.nih.gov
May 14, 2025 at 1:52 AM
Reposted by Dilushi Wijayaratne
brianrifkin.bsky.social
One the one hand, low risk intervention. On the other hand, still unclear benefits.
We doctors like to feel like we are doing something to prevent bad outcomes…but “don’t just do something, sit there” is also appropriate in many patients #NephJC
a man stands in front of a whiteboard with the word wait written on it
ALT: a man stands in front of a whiteboard with the word wait written on it
media.tenor.com
May 14, 2025 at 1:51 AM
dilushiwijay.bsky.social
Not routine, but may be for selected patients #NephJC
May 14, 2025 at 1:53 AM
dilushiwijay.bsky.social
Not exactly the topic, but what about treatment of post biopst bleeds? Is it a single dose of DDAVP, or would your redone? If so do you have a suggested protocol- timing, Na check? #NephJC
May 14, 2025 at 1:50 AM
Reposted by Dilushi Wijayaratne
nephjc.bsky.social
#NephJC

pubmed.ncbi.nlm.nih.gov/7702050/
Defective platelet aggregation in uremia is transiently worsened by hemodialysis - PubMed
Bleeding is a prominent feature of uremia and remains a significant cause of morbidity in hemodialysis (HD)-dependent patients. To measure the impact of the HD procedure, we performed a prospective cr...
pubmed.ncbi.nlm.nih.gov
May 14, 2025 at 1:44 AM